Systemic Therapy in Patients With Metastatic Xp11.2 Translocation Renal Cell Carcinoma.
Sign Up to like & getrecommendations! Published in 2022 at "Clinical genitourinary cancer"
DOI: 10.1200/jco.2022.40.6_suppl.341
Abstract: BACKGROUND Xp11.2 translocation renal cell carcinoma (Xp11.2 tRCC) is a unique subtype with poor prognosis, its response to systemic therapy is not fully understood, we evaluated the benefit of systemic therapy in these patients. PATIENTS… read more here.
Keywords: xp11; months months; metastatic xp11; xp11 trcc ... See more keywords